Physician profile
Patrick L Murphy
NPI 1508849589
$786.57
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $17.91 · 2022: $119 · 2023: $276 · 2024: $14.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $126.04 | 2019 | |
| Spark Therapeutics, INC. | $121.84 | 2019 | |
| Apellis Pharmaceuticals, INC. | $118.91 | 2023 | Syfovre |
| Horizon Therapeutics Plc | $109.80 | 2023 | Tepezza |
| Eyepoint US, INC. | $106.24 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.04 | 2019 | |
| Fresenius Kabi USA, LLC | $24.32 | 2023 | |
| Organon LLC | $22.73 | 2023 | Hadlima |
| Allergan, INC. | $17.91 | 2020 | |
| Janssen Biotech, INC. | $14.45 | 2024 | Tremfya |
| Ani Pharmaceuticals, INC. | $12.96 | 2022 | |
| Clovis Oncology, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.